Beijing, China

Junxing Wan

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Bionaxin Biotech Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junxing Wan. Retrieved from https://idiyas.com/inventor/junxing-wan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junxing Wan: Innovator in Cancer Screening Technology

Introduction

Junxing Wan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in cancer screening methods. His innovative approach focuses on optimizing gene chip probes, which are crucial for early cancer detection.

Latest Patents

Wan holds a patent for an "Optimal selection method of gene chip probes for cancer screening." This invention outlines a method characterized by three stages: constructing a point mutation site (SNV) group, creating a candidate probe group, and verifying and confirming probes based on nucleic acid data from confirmed cancer cases. This method enhances the accuracy and efficiency of cancer screening processes.

Career Highlights

Junxing Wan is associated with Beijing Bionaxin Biotech Co., Ltd., where he applies his expertise in biotechnology to develop innovative solutions for cancer detection. His work has positioned him as a key figure in the advancement of medical technology.

Collaborations

Wan collaborates with notable colleagues, including Ziang Hua and Baoquan Liu, who contribute to his research and development efforts in the field of biotechnology.

Conclusion

Junxing Wan's contributions to cancer screening technology through his patented methods demonstrate his commitment to improving healthcare outcomes. His work continues to influence the biotechnology industry and offers hope for more effective cancer detection methods in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…